catalog
Simple Catalog
| Category | Product name | Ingredients | Form | Strength | Therapeutic Area | timeline | Scope |
|---|---|---|---|---|---|---|---|
| Capecitabine | Tablet | 500mg | |||||
| AK-R214 (SR) | Smoking Cessation | 2017 Clinical Trial | Korea | ||||
| Acarbose | Tablet | 50mg | |||||
| Entacapone | Tablet | 200mg | |||||
| Calcium Acetate | Capsule | 667mg | |||||
| Buprenorphine/Naloxone | Tablet | 8mg/2mg；4mg/1mg；2mg/0.5mg | |||||
| Calcium Citrate | Tablet | 800mg | |||||
| Dextromethorphan Hydrobromide | Tablet | 60mg | |||||
| Cyclobenzaprine Hydrochloride | Tablet | 5mg ; 10mg | |||||
| Baclofen | Tablet | 5mg ; 10mg | |||||
| Diosmin | Tablet | 500mg | |||||
| Desloratadine | Tablet | 5mg | |||||
| Clopidogrel Besylate | Tablet | 75mg | |||||
| Gliclazide | Tablet | 80mg | |||||
| Hydroccortisone Acetate | Ointment | 10mg | |||||
| Entacapone/Carbidopa/Levodopa | Tablet | 200/25/100mg | |||||
| Glucosamine Sulfate | Capsule | 250mg | |||||
| Benzonatate | Soft Capsule | 100mg ; 200mg | |||||
| Megestrol Acetate | Bot | 40mg | |||||
| Letrozole | Tablet | 2.5mg | |||||
| Lenalidomide | Capsule | 2.5mg ; 5mg ; 10mg ; 15mg ; 20mg ; 25mg | |||||
| Temozolomide | Capsule | 5mg ; 20mg ; 100mg ; 140mg ; 180mg ; 250mg | |||||
| Gefitinib | Film-coated Tablet | 250mg | |||||
| Ixabepilone | Vial | 15mg | |||||
| Imatinib | Tablet | 100mg ; 400mg | |||||
| Doxepin Hydrochloride | Cream | 8g ; 15g | |||||
| Butorphanol Tartrate | Nasal Spray | 10mg/ml | |||||
| Cimicifuga Recemosa | Tablet | 6.5mg | |||||
| Trazodone Hydrochloride | Tablet | 25mg ; 50mg ; 150mg | |||||
| Rosuvastatin | Tablet | 10mg | |||||
| Memantine Hydrochloride | Bot | 30ml | |||||
| Memantine Hydrochloride | Tablet | 10mg | |||||
| Mifepristone | Tablet | 200mg | |||||
| Tramadol Hydrochloride | Tablet | 100mg | |||||
| Leflunomide | Tablet | 10mg ; 20mg | |||||
| Irbesartan | Tablet | 300mg | |||||
| Zoledronic Acid | Vial | 5mg/100ml | |||||
| Tramadol Hydrochloride | Capsule | 50mg | |||||
| Lutein | Capsule | 5mg | |||||
| Naltrexone Hydrochloride | Tablet | 100mg | |||||
| Selegiline Hydrochloride | Tablet | 5mg | |||||
| Levetiracetam | Tablet | 500mg ; 750mg | |||||
| Indapamide | Tablet | 1.25mg ; 1.5mg | |||||
| Orlistat | Capsule | 60mg; 120mg | |||||
| Pentoxifylline | Tablet | 400mg | |||||
| Drospirenone/Ethinyl Estradiol | Tablet | 3mg/0.03mg | |||||
| VITA OPC | Sachet | 3.2g | |||||
| Tramadol Hydrochloride | Amp | 100mg/2ml | |||||
| Topiramate | Tablet | 25mg ; 100mg | |||||
| Granisetron | Amp | 3mg/3ml | |||||
| Undenatured Collagen Type II | Capsule | 40mg | |||||
| Acamprosate Calcium | Tablet | 333mg | |||||
| Vinorelbine | Soft Capsule | 20mg ; 30mg ; 80mg | |||||
Newsroom
Latest news
- Investors06 May 2021
Lotus declares cash dividends
Lotus Pharmaceutical Co., Ltd. (“Lotus” or “the Company”, Taiwan TWSE ticker: 1795) today announced that its Board of Directors resolved to declare cash dividends of NT$0.35 per share out of...
- Investors08 September 2022
Monthly sales report for August 2022
- Business05 September 2022
Lotus Launches Lenalidomide Capsules 5mg, 10mg, 15mg, and 25mg, Generic Version of Revlimid® in the US
- Business30 August 2022
Alvogen US, Lotus’s US Investment, Announces Favorable Ruling on Patents Related to the Company’s Proposed Generic to Xifaxan® for IBS-D
- Business25 August 2022
Lotus Receives Tentative Approval for Midostaurin ANDA from the US FDA
- Business22 August 2022
Lotus Crowned as One of Asia’s Best Employers of the Year 2022
- Business16 August 2022
Lotus and Fuji Pharma submitted 1st co-developed high value generic product in Japan
- Investors10 August 2022
Monthly sales report for July 2022
- Investors08 August 2022
Lotus hosts second quarter 2022 results investor conference
- Investors11 July 2022
Monthly sales report for June 2022
